For research teamsHelp me find a study
Back to all studies
CompletedNCT01554462

The Effects of EPA/DHA Supplementation on Cognitive Control in Children With ADHD

This study is completed. It focuses on ADHD and currently lists study information in the Netherlands.

ADHD, HealthyOtherFrom 8 Years to 12 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT01554462. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

What is this study testing?

This study is testing whether the study approach may be useful for adolescents experiencing ADHD.

What would participation involve?

Participants may complete study activities around the study approach, complete questionnaires or follow-up assessments, attend study visits with the research team. The registry lists locations in Netherlands.

Who is it mainly for?

This study appears to be mainly for adolescents with ADHD. Because it involves minors, a parent or guardian may need to be involved.

What should you check before joining?

Ask about whether there is a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.

What to expect

Your next step

The official record suggests in-person participation through a university, with sites including Utrecht University Medical Center; Child and adolescent psychiatry. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually matching the main diagnosis, while common reasons not to take part include major medical issues that could make participation unsuitable and other factors that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateJanuary 2009
Recruitment status
Completed
Estimated enrollment
Not clearly listed
Sponsor
Unilever R&D
Sponsor type
Unknown or unclear
Study type
Other
Intervention type
Other / unclear
Study phase
Not clearly listed
Locations
Netherlands
Age range
From 8 Years to 12 Years
Official registry ID
NCT01554462
Official title
The Effects of EPA/DHA Supplementation on Cognitive Control in Children With ADHD
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT01554462. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Taking part may help clarify how this condition is measured or understood.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in Netherlands.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring blood test or biological sample for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Why is the study type not clearly categorized?

The study type is not clearly categorized in the public registry. Focus on the objective, required tasks, visits, any intervention, and eligibility criteria, then ask the study team to confirm.

Who might this study be for?

This study may concern people with adhd; age range: From 8 Years to 12 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

The public registry does not clearly describe all participation steps. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What risks or points should I check?

The public registry does not make the main risk category clear. Ask the study team what activities are required, what could feel uncomfortable, how safety is monitored, and what happens if you want to stop. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Unilever R&D, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The registry indicates that this study is completed. It may still be useful for understanding the research, but you are unlikely to be able to join.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.